This inventor holds 1 USPTO granted patent. Top assignee: Memorial Sloan Kettering Cancer Center. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations in Cancer Treatment by Sang Gyu Lee
Introduction
Sang Gyu Lee is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cancer research, particularly in the development of novel therapeutic agents. His work focuses on improving the detection and treatment of PSMA positive cancers.
Latest Patents
Sang Gyu Lee holds 1 patent for his invention titled "Theranostic agents for PSMA positive cancers." This patent provides compositions and methods for the detection and treatment of cancer. The technology includes novel radiohalogenated PSMA targeting agents, which are utilized in diagnostic imaging and radiation therapy.
Career Highlights
Sang Gyu Lee is affiliated with the Memorial Sloan Kettering Cancer Center, a leading institution in cancer treatment and research. His work at this prestigious center has allowed him to collaborate with other experts in the field and contribute to groundbreaking advancements in cancer therapy.
Collaborations
One of his notable coworkers is Teja Muralidhar Kalidindi. Their collaboration has further enhanced the research efforts at Memorial Sloan Kettering Cancer Center.
Conclusion
Sang Gyu Lee's innovative work in developing theranostic agents represents a significant advancement in the fight against cancer. His contributions are paving the way for more effective diagnostic and treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile